Galectin Therapeutics (GALT) EPS (Basic) Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,207.14% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 46.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.67% |
| Dec 31, 2025 | 57.89% |
| Sep 30, 2025 | 27.78% |
| Jun 30, 2025 | 40.00% |
| Mar 31, 2025 | 21.05% |
| Dec 31, 2024 | -18.75% |
| Sep 30, 2024 | 25.00% |
| Jun 30, 2024 | -33.33% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 11.11% |
| Sep 30, 2023 | -71.43% |
| Jun 30, 2023 | 6.25% |
| Mar 31, 2023 | -11.76% |
| Dec 31, 2022 | -50.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -6.67% |
| Mar 31, 2022 | -54.55% |
| Dec 31, 2021 | 7.69% |
| Sep 30, 2021 | -40.00% |
| Jun 30, 2021 | -36.36% |
| Mar 31, 2021 | -83.33% |
| Dec 31, 2020 | -8.33% |
| Sep 30, 2020 | -100.00% |
| Jun 30, 2020 | -83.33% |
| Mar 31, 2020 | 70.00% |
| Dec 31, 2019 | 82.35% |
| Sep 30, 2019 | -171.43% |
| Jun 30, 2019 | -154.55% |
| Mar 31, 2019 | -266.67% |
| Dec 31, 2018 | -871.43% |
| Sep 30, 2018 | 153.85% |
| Jun 30, 2018 | 178.57% |
| Mar 31, 2018 | 180.00% |
| Dec 31, 2017 | 56.25% |
| Sep 30, 2017 | 18.75% |
| Jun 30, 2017 | 30.00% |
| Mar 31, 2017 | 37.50% |
| Dec 31, 2016 | 15.79% |
| Sep 30, 2016 | 38.46% |
| Jun 30, 2016 | 4.76% |
| Mar 31, 2016 | -9.09% |
| Dec 31, 2015 | -11.76% |
| Sep 30, 2015 | -52.94% |
| Jun 30, 2015 | -23.53% |
| Mar 31, 2015 | 18.52% |
| Dec 31, 2014 | -21.43% |
| Sep 30, 2014 | 22.73% |
| Jun 30, 2014 | 76.39% |
| Mar 31, 2014 | -22.73% |
| Dec 31, 2013 | 17.65% |
| Sep 30, 2013 | -15.79% |
| Jun 30, 2013 | -278.95% |
| Mar 31, 2013 | -29.41% |
| Dec 31, 2012 | 41.38% |
| Sep 30, 2012 | 0.00% |
| Jun 30, 2012 | 44.12% |
| Mar 31, 2012 | 29.17% |
| Dec 31, 2011 | 63.75% |
| Sep 30, 2011 | -533.33% |
| Jun 30, 2011 | -580.00% |